BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fuentes JL, Strayer MS, Matera AG. Molecular determinants of survival motor neuron (SMN) protein cleavage by the calcium-activated protease, calpain. PLoS One 2010;5:e15769. [PMID: 21209906 DOI: 10.1371/journal.pone.0015769] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Menduti G, Rasà DM, Stanga S, Boido M. Drug Screening and Drug Repositioning as Promising Therapeutic Approaches for Spinal Muscular Atrophy Treatment. Front Pharmacol 2020;11:592234. [PMID: 33281605 DOI: 10.3389/fphar.2020.592234] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 de la Fuente S, Sansa A, Periyakaruppiah A, Garcera A, Soler RM. Calpain Inhibition Increases SMN Protein in Spinal Cord Motoneurons and Ameliorates the Spinal Muscular Atrophy Phenotype in Mice. Mol Neurobiol 2019;56:4414-27. [PMID: 30327977 DOI: 10.1007/s12035-018-1379-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
3 Anderton RS, Meloni BP, Mastaglia FL, Boulos S. Spinal muscular atrophy and the antiapoptotic role of survival of motor neuron (SMN) protein. Mol Neurobiol 2013;47:821-32. [PMID: 23315303 DOI: 10.1007/s12035-013-8399-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
4 Sarachan KL, Valentine KG, Gupta K, Moorman VR, Gledhill JM Jr, Bernens M, Tommos C, Wand AJ, Van Duyne GD. Solution structure of the core SMN-Gemin2 complex. Biochem J 2012;445:361-70. [PMID: 22607171 DOI: 10.1042/BJ20120241] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
5 Periyakaruppiah A, de la Fuente S, Arumugam S, Bahí N, Garcera A, Soler RM. Autophagy modulators regulate survival motor neuron protein stability in motoneurons. Exp Neurol 2016;283:287-97. [PMID: 27373203 DOI: 10.1016/j.expneurol.2016.06.032] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
6 Locatelli D, Terao M, Kurosaki M, Zanellati MC, Pletto DR, Finardi A, Colciaghi F, Garattini E, Battaglia GS. Different Stability and Proteasome-Mediated Degradation Rate of SMN Protein Isoforms. PLoS One 2015;10:e0134163. [PMID: 26214005 DOI: 10.1371/journal.pone.0134163] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
7 Dury AY, El Fatimy R, Tremblay S, Rose TM, Côté J, De Koninck P, Khandjian EW. Nuclear Fragile X Mental Retardation Protein is localized to Cajal bodies. PLoS Genet 2013;9:e1003890. [PMID: 24204304 DOI: 10.1371/journal.pgen.1003890] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
8 Ono Y, Ojima K, Shinkai-ouchi F, Hata S, Sorimachi H. An eccentric calpain, CAPN3/p94/calpain-3. Biochimie 2016;122:169-87. [DOI: 10.1016/j.biochi.2015.09.010] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 9.8] [Reference Citation Analysis]
9 Carrero ZI, Velma V, Douglas HE, Hebert MD. Coilin phosphomutants disrupt Cajal body formation, reduce cell proliferation and produce a distinct coilin degradation product. PLoS One 2011;6:e25743. [PMID: 21991343 DOI: 10.1371/journal.pone.0025743] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
10 Velma V, Broome HJ, Hebert MD. Regulated specific proteolysis of the Cajal body marker protein coilin. Chromosoma 2012;121:629-42. [PMID: 23064547 DOI: 10.1007/s00412-012-0387-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
11 Wang H, Zhai N, Chen Y, Xu H, Huang K. Cadmium induces Ca 2+ mediated, calpain-1/caspase-3-dependent apoptosis in primary cultured rat proximal tubular cells. Journal of Inorganic Biochemistry 2017;172:16-22. [DOI: 10.1016/j.jinorgbio.2017.04.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
12 de la Fuente S, Sansa A, Hidalgo I, Vivancos N, Romero-Guevara R, Garcera A, Soler RM. Calpain system is altered in survival motor neuron-reduced cells from in vitro and in vivo spinal muscular atrophy models. Cell Death Dis 2020;11:487. [PMID: 32587237 DOI: 10.1038/s41419-020-2688-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Wang Y, Xu C, Ma L, Mou Y, Zhang B, Zhou S, Tian Y, Trinh J, Zhang X, Li XJ. Drug screening with human SMN2 reporter identifies SMN protein stabilizers to correct SMA pathology. Life Sci Alliance 2019;2:e201800268. [PMID: 30910806 DOI: 10.26508/lsa.201800268] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
14 Cherry JJ, Kobayashi DT, Lynes MM, Naryshkin NN, Tiziano FD, Zaworski PG, Rubin LL, Jarecki J. Assays for the identification and prioritization of drug candidates for spinal muscular atrophy. Assay Drug Dev Technol 2014;12:315-41. [PMID: 25147906 DOI: 10.1089/adt.2014.587] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
15 Singh NN, Seo J, Rahn SJ, Singh RN. A multi-exon-skipping detection assay reveals surprising diversity of splice isoforms of spinal muscular atrophy genes. PLoS One 2012;7:e49595. [PMID: 23185376 DOI: 10.1371/journal.pone.0049595] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
16 Araujo H, Julio A, Cardoso M. Translating genetic, biochemical and structural information to the calpain view of development. Mechanisms of Development 2018;154:240-50. [DOI: 10.1016/j.mod.2018.07.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]